Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Vaccines

Sublethal Staphylococcal Enterotoxin B Challenge Model in Pigs To Evaluate Protection following Immunization with a Soybean-Derived Vaccine

Laura C. Hudson, Brynn S. Seabolt, Jack Odle, Kenneth L. Bost, Chad H. Stahl, Kenneth J. Piller
Laura C. Hudson
aDepartment of Biology, University of North Carolina at Charlotte, Charlotte, North Carolina, USA
bSoyMeds, Inc., Davidson, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brynn S. Seabolt
cLaboratory of Developmental Nutrition, Department of Animal Science, North Carolina State University, Raleigh, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack Odle
cLaboratory of Developmental Nutrition, Department of Animal Science, North Carolina State University, Raleigh, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth L. Bost
aDepartment of Biology, University of North Carolina at Charlotte, Charlotte, North Carolina, USA
bSoyMeds, Inc., Davidson, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chad H. Stahl
cLaboratory of Developmental Nutrition, Department of Animal Science, North Carolina State University, Raleigh, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth J. Piller
aDepartment of Biology, University of North Carolina at Charlotte, Charlotte, North Carolina, USA
bSoyMeds, Inc., Davidson, North Carolina, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.00526-12
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig 1
    • Open in new tab
    • Download powerpoint
    Fig 1

    Purification, quantification, and stability of soy-mSEB. Soybean-derived mSEB (soy-mSEB) was expressed in transgenic soybean seeds and purified by affinity chromatography as outlined in Materials and Methods. (A) Representative Coomassie blue-stained SDS-PAGE gel. (B) Representative Western blot of crude soybean extract (10 μg) next to purified extract (1 μg), each demonstrating a single band of soy-mSEB at approximately 28 kDa. (C) Representative Western blot used for quantification of soy-mSEB purified from seed extracts relative to recombinant SEB standards. (D) (Left) Western blot analysis of soymilk protein (10 μg) extracted from T1 seeds expressing mSEB. Seeds were harvested in 2009 and stored for 3 years at ambient temperature. (Right) Digestion of recombinant mSEB (2 μg) with increasing amounts of protease. The migration of molecular size standard proteins is shown in kilodaltons in all panels.

  • Fig 2
    • Open in new tab
    • Download powerpoint
    Fig 2

    Soy-mSEB lacks superantigen activity in pig lymphocytes. Pig splenic leukocytes were isolated and then cultured in the presence of the indicated concentrations of native SEB (nSEB) or soy-mSEB. After 48 h of culture, culture supernates were taken and porcine IFN-γ secretion determined using an ELISA. Results are presented as mean values (plus SEM) for triplicate determinations. Levels of gamma interferon that were below the 50-pg/ml detection limit for this ELISA were designated nondetectable (ND).

  • Fig 3
    • Open in new tab
    • Download powerpoint
    Fig 3

    Immunization of pigs with soy-mSEB and E. coli-mSEB results in high antitoxin serum titers. Groups of 25-day-old pigs (n = 5) were immunized intramuscularly (day 0) and then boosted on days 14 and 28 with E. coli-mSEB or soy-mSEB in alum. Control pigs were immunized with an equal amount of buffer containing alum. (A) Representative Coomassie blue-stained SDS-PAGE gel and accompanying Western blot, demonstrating the purity of each immunogen. Each animal was bled just prior to immunization on days 0, 14, 28, and 38. (B) ELISAs were performed to determine serum IgG anti-native SEB reactivity. These data are presented as mean anti-native SEB titers (plus SEM).

  • Fig 4
    • Open in new tab
    • Download powerpoint
    Fig 4

    Antibodies from pigs immunized with soy-mSEB and E. coli-mSEB effectively neutralized native SEB activity in vitro. Sera collected at day 38 postimmunization were used in an in vitro neutralization assay to demonstrate the ability to limit native SEB-induced cytokine responses. Dilutions (1:33 or 1:100) of sera from soy-mSEB-immunized, E. coli-mSEB-immunized, or control animals were mixed with 0.5 μg/ml of native SEB for 30 min prior to the addition of the mixtures to cultures of pig splenic leukocytes. Forty-eight hours after coincubation, culture supernates were taken and porcine IFN-γ secretion determined using an ELISA. Results are presented as mean values (plus SEM) for triplicate determinations for each immunogen group (n = 3 or 4). Asterisks indicate statistically significant differences (P < 0.01) compared to control animals.

  • Fig 5
    • Open in new tab
    • Download powerpoint
    Fig 5

    Reduced cytokine responses in pigs immunized with soy-mSEB and E. coli-mSEB following challenge with a sublethal dose of native SEB. At 36 to 38 days postimmunization, pigs had intravenous catheters surgically implanted to facilitate toxin administration and to allow for rapid and frequent blood collection. At days 38 to 40 postimmunization, pigs (n = 3 to 5) were challenged intravenously with a sublethal dose of native SEB (25 μg/kg). Blood was taken at the indicated hours postchallenge for quantification of IL-1β (A), IL-6 (B), IL-8 (C), IL-12p40 (D), IFN-γ (E), and TNF-α (F). For each time postchallenge (0, 1, 2, 3, 4, 8, 12, and 24 h), cytokines in sera (ng/ml) are presented as mean levels (plus SEM) for each group (n = 3 to 5) of immunized pigs. Asterisks indicate P values of <0.05 for comparing control values to values obtained for soy-mSEB- or E. coli-mSEB-immunized animals.

Tables

  • Figures
  • Table 1

    Comparison of E. coli- and soybean-derived mSEB starting materials and yields

    Expression systemaVol of starting material (liters)bStarting biomasscTotal soluble protein from biomassdRecoverable yield of vaccine (g)e
    E. coli cell culture56.5 (from fermentor)2,543 g of bacterial cell pellet28.127 g8.297
    Transgenic soybean seeds1.0 (soy powder)800 g of soy powder per liter320.000 g of protein per liter (theoretical)12.800 (theoretical)
    • ↵a E. coli-derived mutant SEB (L45R/Y89A/Y94A) was produced as described previously (6). Soy-mSEB was produced as described in Materials and Methods.

    • ↵b The volume of E. coli cell culture was taken from a previous report (41). One liter of soy powder made by grinding transgenic seeds expressing soy-mSEB is used as a theoretical comparison.

    • ↵c The starting biomass of E. coli-mSEB required medium filtration and concentration of the cell pellet. The size of the pellet mass was taken from a previous report (41). One liter of soy powder equals approximately 800 g and required no additional concentration or manipulation.

    • ↵d The total soluble protein extracted from the E. coli cell pellet was taken from a previous report (41). Theoretically, 320 g of protein can be extracted from 800 g of soy powder, since approximately 40% of the total mass is protein (42). This number assumes minimal loss of protein during the extraction procedure.

    • ↵e The total recoverable yield of E. coli-mSEB was taken from a previous report (41). Theoretically, for transgenic seeds expressing soy-mSEB at 4%, 320 g of total protein contains approximately 12.8 g of soy-mSEB (42). This number does not account for any losses during the purification procedures.

PreviousNext
Back to top
Download PDF
Citation Tools
Sublethal Staphylococcal Enterotoxin B Challenge Model in Pigs To Evaluate Protection following Immunization with a Soybean-Derived Vaccine
Laura C. Hudson, Brynn S. Seabolt, Jack Odle, Kenneth L. Bost, Chad H. Stahl, Kenneth J. Piller
Clinical and Vaccine Immunology Jan 2013, 20 (1) 24-32; DOI: 10.1128/CVI.00526-12

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sublethal Staphylococcal Enterotoxin B Challenge Model in Pigs To Evaluate Protection following Immunization with a Soybean-Derived Vaccine
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Sublethal Staphylococcal Enterotoxin B Challenge Model in Pigs To Evaluate Protection following Immunization with a Soybean-Derived Vaccine
Laura C. Hudson, Brynn S. Seabolt, Jack Odle, Kenneth L. Bost, Chad H. Stahl, Kenneth J. Piller
Clinical and Vaccine Immunology Jan 2013, 20 (1) 24-32; DOI: 10.1128/CVI.00526-12
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X